August 31, 2022

Press release

FluoGuide appoints new CFO

Copenhagen, Denmark, 31 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) has today appointed Henrik Hang as Chief Financial Officer... [Read more]

August 30, 2022

Press release

FluoGuide receives permission to start phase IIb trial in aggressive brain cancer

Copenhagen, Denmark, 30 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the company now has... [Read more]

August 25, 2022

Press release

FluoGuide A/S publishes interim report for the period January – June 2022

Copenhagen, Denmark, 25 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January... [Read more]

August 24, 2022

Press release

FluoGuide’s update on FG001’s clinical development

Copenhagen, Denmark, 24 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical development of FG001.... [Read more]

August 23, 2022

Press release

FluoGuide has submitted a Clinical Trial Application (CTA) to the Danish Medicines Agency to initiate phase II trial with FG001 in head and neck cancer

Copenhagen, Denmark 23 August 2022– FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has submitted a... [Read more]

August 22, 2022

Press release

Publication of clinical data confirming uPAR as an attractive target for guiding surgery in head and neck cancer

Copenhagen, Denmark, 22 August 2022. FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce a publication of clinical data that... [Read more]

August 16, 2022

News

Investor presentations for FluoGuide in H2 2022

Copenhagen, Denmark, 16 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Morten Albrechtsen, CEO of... [Read more]

May 31, 2022

Press release

FluoGuide A/S publishes interim report for the period January – March 2022

Copenhagen, Denmark, 31 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January... [Read more]

May 23, 2022

Press release

FluoGuide publish the presentation of FG001 results from the first clinical trial in aggressive brain cancer

Copenhagen, Denmark, 23 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the presentation of the... [Read more]